HispanicHedge

Lipocine $LPCN 4th Submission Run-up

NASDAQ:LPCN   Lipocine Inc.
Lipocine Inc $LPCN has a PDUFA on Aug. 28 for Tlando, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed to help restore normal testosterone levels in hypogonadal men.

Lipocine Announces Derivative Suit Was Dismissed 7/31/2020
www.prnewswire.com/n...issed-301103629.html

I really like how this chart is setting up over the $1.60 level if volume continues. There is a lot of short squeeze potential in the name, and always manage your risk.

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.